OtherClinical Investigations
The Utility of 18F-FDG PET for Suspected Recurrent Non–Small Cell Lung Cancer After Potentially Curative Therapy: Impact on Management and Prognostic Stratification
Rodney J. Hicks, Victor Kalff, Michael P. MacManus, Robert E. Ware, Allan F. McKenzie, Jane P. Matthews and David L. Ball
Journal of Nuclear Medicine November 2001, 42 (11) 1605-1613;
Rodney J. Hicks
Victor Kalff
Michael P. MacManus
Robert E. Ware
Allan F. McKenzie
Jane P. Matthews
In this issue
The Utility of 18F-FDG PET for Suspected Recurrent Non–Small Cell Lung Cancer After Potentially Curative Therapy: Impact on Management and Prognostic Stratification
Rodney J. Hicks, Victor Kalff, Michael P. MacManus, Robert E. Ware, Allan F. McKenzie, Jane P. Matthews, David L. Ball
Journal of Nuclear Medicine Nov 2001, 42 (11) 1605-1613;
The Utility of 18F-FDG PET for Suspected Recurrent Non–Small Cell Lung Cancer After Potentially Curative Therapy: Impact on Management and Prognostic Stratification
Rodney J. Hicks, Victor Kalff, Michael P. MacManus, Robert E. Ware, Allan F. McKenzie, Jane P. Matthews, David L. Ball
Journal of Nuclear Medicine Nov 2001, 42 (11) 1605-1613;
Jump to section
Related Articles
- No related articles found.
Cited By...
- The Injustice of Being Judged by the Errors of Others: The Tragic Tale of the Battle for PET Reimbursement
- Response Assessment Criteria and Their Applications in Lymphoma: Part 1
- 18F-FDG PET/CT and Lung Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management
- Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients
- Improvement in PET/CT Image Quality with a Combination of Point-Spread Function and Time-of-Flight in Relation to Reconstruction Parameters
- Doing More Harm than Good? Do Systematic Reviews of PET by Health Technology Assessment Agencies Provide an Appraisal of the Evidence That Is Closer to the Truth than the Primary Data Supporting Its Use?
- The role of positron emission tomography in the management of non-small cell lung cancer
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- Partnerships in Oncology and Radiology: The Role of Radiology in the Detection, Staging, and Follow-up of Lung Cancer
- PET Evaluation of Lung Cancer
- Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
- The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
- PET/CT Using 18F-FDG in Suspected Lung Cancer Recurrence: Diagnostic Value and Impact on Patient Management
- Quantification of 18F-FDG Uptake in Non-Small Cell Lung Cancer: A Feasible Prognostic Marker?
- American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003
- Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non-Small-Cell Lung Cancer
- Use of a Dual-Head Coincidence Camera and 18F-FDG for Detection and Nodal Staging of Non-Small Cell Lung Cancer: Accuracy as Determined by 2 Independent Observers